# PFx Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/pfx-biotech

- Industry: Biotechnology
- Headquarters: Porto, Portugal
- Website: www.pfxbiotech.com
- Total disclosed funding: $2.9M
- Latest round: Seed (Jun 6, 2025)
- Investors on record: 3

## About

PFx Biotech, based in Porto, Portugal, focuses on innovative solutions in protein development, leveraging precision fermentation to create tailored nutrition products for diverse applications.Founded in 2022, PFx Biotech specializes in advanced protein solutions through precision fermentation. The company has secured EUR 2.5 mn in funding during its SEED round, led by Buenavista Equity Partners, S.L., with participation from Beta Capital and EIT Food. PFx Biotech has completed 2 deals, with its latest deal occurring on June 6, 2025.PFx Biotech specializes in the development and production of advanced protein solutions through a unique precision fermentation platform. Their core offerings include highly bioactive human milk protein ingredients tailored for diverse nutrition applications, such as sports performance, medical nutrition, elderly care, and early-life development. By employing a systems biology approach, PFx Biotech creates alternative proteins that cater to specific dietary needs while addressing the broader challenges associated with food-related carbon emissions. The company successfully targets markets in North America, Europe, and Asia, serving a wide range of clients from health and wellness brands to food manufacturers focused on innovative nutritional products. These products are designed to provide effective solutions for individuals with dietary restrictions and enhance overall health and wellness.PFx Biotech generates revenue through strategic partnerships and direct sales of their advanced protein solutions to both businesses and consumers. The company's business model involves B2B transactions with nutritional supplement brands, healthcare providers, and food manufacturers, allowing them to incorporate PFx Biotech’s proprietary protein ingredients into their own products. Pricing plans for these flagship offerings are structured to reflect the quality and innovation of their solutions, with transactions typically negotiated on a case-by-case basis depending on the volume and specific requirements of the client. Through these collaborations, PFx Biotech aims to establish long-term relationships while ensuring their products deliver measurable benefits to end-users, thereby fostering brand loyalty and repeat business within the growing advanced nutrition market.In June 2025, PFx Biotech raised EUR 2.5 mn in grant funding from the European Innovation Council to support its growth initiatives. The company plans to expand its product offerings, focusing on new protein solutions tailored to emerging nutritional needs. Additionally, PFx Biotech aims to enhance its reach into new geographic regions, specifically targeting markets in Europe and Asia by 2026.

## Funding rounds

- Seed, Jun 6, 2025, $2.9M — Buenavista Equity Partners, Beta Capital, EIT Food

## Investors

- Buenavista Equity Partners (https://capitalatlas.ai/funds/buenavista-equity-partners) — Seed
- Beta Capital (https://capitalatlas.ai/funds/beta-capital) — Seed
- EIT Food — Seed